Completed PHASE3 INTERVENTIONAL 2-arm NCT01535417

Efficacy and Safety of Shinbaro Capsule

A 12 Weeks, Randomized, Double-blind, Multi-centers, Phase III Study to Evaluate the Efficacy and Safety of Shinbaro Capsule Compared With Celebrex Capsule in Patients With Osteoarthritis of Knee

Sponsor: Green Cross Corporation

Conditions Osteoarthritis

Interventions Celebrex Shinbaro Capsule

Updated 6 times since 2017 Last updated: Feb 14, 2012 Started: May 31, 2009 Primary completion: Dec 31, 2009 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01535417, this PHASE3 trial focuses on Osteoarthritis and remains completed. Sponsored by Green Cross Corporation, it has been updated 6 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jul 2022 — Jul 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2022 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

May 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Green Cross Corporation

Data source: GC Biopharma Corp

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.